Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Posts Tagged ‘NASDAQ:SRPT’
Here’s Why Artisan Partners Disposed its Sarepta Therapeutics Inc. (SRPT) Position
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded...
Is SRPT Stock A Buy or Sell?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is SRPT A Good Stock To Buy Now According To Hedge Funds?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
12 Best Large Biotech Stocks to Buy Now
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
Sarepta Therapeutics Inc (SRPT): Are Hedge Funds Right About This Stock?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Are Crazy About Sarepta Therapeutics Inc (SRPT)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On Sarepta Therapeutics Inc (SRPT) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Is Sarepta Therapeutics Inc (SRPT) Going to Burn These Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Do Hedge Funds Love Sarepta Therapeutics Inc (SRPT)?
Coronavirus is probably the #1 concern in investors’ minds right now. It should be.
How Did Sarepta Therapeutics Inc (SRPT) Compare Against Top Hedge Fund Stocks in 2019?
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
Did Hedge Funds Drop The Ball On Sarepta Therapeutics Inc (SRPT) ?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money ...
Hedge Funds Have Never Been This Bullish On Sarepta Therapeutics Inc (SRPT)
Is Sarepta Therapeutics Inc (NASDAQ:SRPT) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Here’s What Hedge Funds Think About Sarepta Therapeutics Inc (SRPT)
Is Sarepta Therapeutics Inc (NASDAQ:SRPT) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Here is What Hedge Funds Think About Sarepta Therapeutics Inc (SRPT)
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC.
Is Sarepta Therapeutics Inc (SRPT) A Good Stock To Buy?
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money...
Hedge Funds Just Stormed Into This Red-Hot Biotech Company
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
The 25 Biggest Insider Purchases in October
Insider purchases consistently outpaced insider sales during much of October, the first time that has happened over a minimum two-week period since January 2016.
Here’s What Is Going On In The Financial Markets Today?
"U.S. stocks traded firmly higher Wednesday, with the Nasdaq Composite setting an intraday record, after a strong reading on private-sector hiring in March.
Why Sarepta Therapeutics Inc (SRPT) Shares Are Surging
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have popped 4% after Edward Nash of SunTrust upgraded the equity to 'Buy' from 'Hold' and set a $45 target price.
What Do Hedge Funds Think of Sarepta Therapeutics Inc (SRPT)?
In a rather quiet market where the Dow is down but the S&P and NASDAQ are both up, Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have rallied 3%, showing some solid relative...
Sarepta Therapeutics Inc (SRPT) Gets Off To A Running Start With Eteplirsen
Sarepta Therapeutics Inc (NASDAQ:SRPT) is one of the week’s biggest winners from the J.P.
Hedge Funds Are Crazy About Sarepta Therapeutics Inc (SRPT)
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
5 Medical Tech Stocks You Should Be Investing In
The medical sector is growing rapidly and getting in on the ground floor with med tech can be highly profitable for smart investors, but how can you know which stocks to choose...
Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed
Joseph Edelman's Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being invested in healthcare stocks.
Sarepta Therapeutics Inc. (SRPT) Stock: Jason Karp Is A Shareholder Again And Has A Larger Position Than Ever
Jason Karp's Tourbillon Capital Partners has retaken a stake in Sarepta Therapeutics Inc (NASDAQ:SRPT) after having sold off its previous position in the stock during the second...
Sarepta Therapeutics Inc (SRPT) Stock: “Eteplirsen Approval Controversy Rages On”
If you follow Sarepta Therapeutics Inc (NASDAQ:SRPT), you know about Eteplirsen. The treatment is designed to treat several diseases, including Duchenne muscular dystrophy.
Today’s Trending Stocks: Sarepta, Humana, HTG Molecular Diagnostics, and More
After yesterday's rather sharp fall, Wall Street is quiet today as the Dow is up only 14 points while the NASDAQ is 0.01% in the green. In this article, we analyze some stocks...
Why Sarepta Therapeutics, Ralph Lauren, Fifth Third Bancorp, and Two Other Stocks Are in Spotlight on Friday
WTI crude futures have sank below the $50 per barrel mark around noon as traders brace for another potential rise in the rig count.
Here’s Why These Five Stocks Are Trading Higher Today
Broad markets are shaky today with NASDAQ trading in red territory.
Rite Aid Corporation, WCI Communities & Other Stocks in Spotlight Following Earnings, M&A News and More
Wall Street is quiet today after the Federal Reserve's Wednesday decision of keeping interest rates the same.
Sarepta Soars to 150% Q3 Gains, Wal-Mart Closes Jet Deal, SeaWorld Sinks & More
Among the stocks capturing attention from traders early this morning are SeaWorld Entertainment Inc (NYSE:SEAS), Ascena Retail Group Inc (NASDAQ:ASNA), Wal-Mart Stores, Inc.
Sarepta Therapeutics Inc (SRPT), PTC Therapeutics, Inc. (PTCT) and More: Here’s Why These Stocks Are on Investors’ Radars Today
Wall Street is in bull mode today as all three major indexes are in the green, with the Dow rising 90 points, the S&P 500 increasing 0.5% and the NASDAQ inching up 0.4%.
Why Sarepta, Glu Mobile, Harmony Gold and 2 Other Stocks Are On The Move Today
Some stocks are nonetheless gaining ground this morning, including Sarepta Therapeutics Inc (NASDAQ:SRPT), At Home Group Inc.
Summit Therapeutics PLC (ADR) (SMMT) Is Hot On Sarepta Therapeutics Inc (SRPT)’s DMD Tail
Duchenne’s Muscular Dystrophy (DMD) is a hot topic right now.
Why GE, Yahoo, and 3 Other Stocks Are Trending This Morning
The markets are in the green ahead of Tuesday's opening bell, with the S&P, Nasdaq, and Dow futures are all in positive territory, as are crude futures.
Why AMD, Hovnanian, and Three Other Stocks Are Down Today
The markets have been quiet so far today, amid news involving the ADP private payrolls rising by 173,000 for May and OPEC agreeing to maintain the status quo.
Sarepta Therapeutics Inc (SRPT) Soaring as FDA Postpones Eteplirsen Review, Raising Hopes of an Approval
Sarepta Therapeutics Inc (NASDAQ:SRPT) is up by 16% this morning after the FDA informed the company that it needs additional time to complete the review of the New Drug Application...
Why Facebook, Opower, Genworth, Apollo Education, and Sarepta Are Spiking Today
Even though oil is down on Monday, U.S stocks are up, partly driven by strength in the financial and consumer discretionary sectors.
Why Are Investors Piling Into These Surging Stocks?
Although the Dow Jones Index and the S&P 500 are each close to flat for the day, shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Textura Corp (NYSE:TXTR), Cliffs Natural...
Why You Should Watch These Five Stocks Today?
Markets opened higher on Tuesday as companies continue to announce quarterly financial results. A Federal Reserve policy meeting is also scheduled to start today.
Here’s Why These 5 Stocks Are Deep in the Red Today
Although crude futures have rallied to almost break-even and most of the major earnings reports released so far aren't sharply negative in terms of those company's macro-economic...
Two Healthcare Companies and One Micro-Cap Company Register Strong Insider Buying
Piggybacking insider trading has been a profitable investment strategy over the past several decades or so based on research, though new regulations and an increased use of stock...
Top Biotech Picks of Best-Performing Hedge Fund of 2015
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top of the list was biotech...
Four of the Biggest Movers on a Volatile Friday Morning
Market fear just isn't going away. With S&P futures down by 2% in the pre-market and crude prices breaking below $30 per barrel, Friday looks to be another volatile day.
Is Sarepta Therapeutics Inc (SRPT) A Good Stock To Buy?
The third quarter was a rough one for most investors, as fears of an interest rate hike in the U.S, a weakening economy in China, and a stagnant Europe, weighed heavily on the...
Here’s Why These Five Stocks Are Plunging Today
With markets slightly in the red on Wednesday, a number of stocks stood out as they are plunging in afternoon trading.
